Skip to main content
Log in

Case Report: Chronic Liver Injury Related to Use of Bentazepam

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. Lee WM: Drug-induced hepatotoxicity. N Engl J Med 333:1118–1127, 1995

    Google Scholar 

  2. Farrell GC (ed): Drug-Induced Liver Disease. London, Churchill Livingstone, 1994

    Google Scholar 

  3. Bass NM, Ockner RK: Drug-induced liver disease. In D Zakim, TD Boyer (eds). Hepatology: A Textbook of Liver Disease, 3rd ed. Philadelphia, WB Saunders, 1996, pp 962–1017

    Google Scholar 

  4. Consejo General de Colegios Oficiales de Farmaceúticos: Catálogo de especialidades farmaceúticas. Madrid, Einsa, 1998

    Google Scholar 

  5. Honorato J, Rubio A, Tristán C, Otero FJ, Garrido J: Estudio de farmacovigilancia con bentazepam en una muestra de 1046 pacientes psiquiátricos ambulatorios. Rev Med Univ Navarra 34:80–88, 1990

    Google Scholar 

  6. Andrade RJ, Lucena MI, Alcántara R, Fraile JM: Bentazepam-associated chronic liver disease. Lancet 343:860, 1994

    Google Scholar 

  7. Zimmerman HJ: Hepatotoxicity. Dis Month 39:675–787, 1993

    Google Scholar 

  8. Sherlock S: The spectrum of hepatotoxicity due to drugs. Lancet 2:440–444, 1986

    Google Scholar 

  9. Farrell GC: Drug-induced chronic active hepatitis. In GC Farrell (ed). Drug-Induced Liver Disease. London, Churchill Livingston, 1994, pp 413–430

    Google Scholar 

  10. De la Serna C, Gil-Grande LA, Sanroman AL, Gonzalez M, Ruiz del Arbol L, Garcia Plaza A: Bentazepam-induced hepatic bridging necrosis. J Clin Gastroenterol 25:710–711, 1997

    Google Scholar 

  11. Consensus-criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 11;272–276, 1990

  12. Fernandez-Tomé MP, Fuentes JA, Madroñero R, del Río J: Pharmacological properties of 6,7-tetramethylene-5-phenyl-1,2-dihydro-3H-thieno[2,3-e (1,4)-diazepin-2-one (QM-6008, Thiadipone), a new psychotropic drug. Arzneim Forsch Drug Res 25:926–934, 1975

    Google Scholar 

  13. Habersetzer F, Larrey D, Babany G, Degott C, Corbic M, Pessayre D, Benhamou JP: Clotiazepam-induced acute hepatitis. J Hepatol 9:256–259, 1989

    Google Scholar 

  14. Imler M, Chabrier G, Cherfan J, Simon C: Hepatitis caused by thiophene. Gastroenterol Clin Biol 11:173–174, 1987

    Google Scholar 

  15. Pouderoux P, Pageaux G, Duhamel O, Gilson J: A new case of hepatitis caused by thiopeol. Gastroenterol Clin Biol 12:673–674, 1988

    Google Scholar 

  16. Idiope-Tomás A, Martínez-Larrañaga MR, Alsasua del Valle A, González-Fernández E, García de Jalón P: Cinética de eliminación de la tiadipona. Arch Farmacol Toxicol 2:123–132, 1976

    Google Scholar 

  17. González-López F, Mariño EL, Dominguez-Gil A: Pharmacokinetics of tiadipone: A new anxiolytic. Int J Clin Pharmacol Ther Toxicol 482–484, 1986

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andrade, R., Lucena, M., Aguilar, J. et al. Case Report: Chronic Liver Injury Related to Use of Bentazepam. Dig Dis Sci 45, 1400–1404 (2000). https://doi.org/10.1023/A:1005520523502

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005520523502

Navigation